ALHC names COO Hochradel as Form 3 insider

Alignment Healthcare, Inc. filed an initial Form 3 for Shane J. Hochradel, who serves as Chief Operations Officer.

Accepted by SEC EDGAR 06/02/2026 - 06:52 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Alignment Healthcare, Inc. filed an initial Form 3 for Shane J. Hochradel, who serves as Chief Operations Officer. This filing establishes him as a reporting person for Alignment Healthcare equity. The submission reports no insider transactions or holdings details in the disclosed data.

Key Terms

Form 3, reporting person, Chief Operations Officer

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

"This filing establishes him as a reporting person for Alignment Healthcare equity."

Chief Operations Officer financial

""officer_title": "Chief Operations Officer""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing for ALHC and Shane J. Hochradel represent?

The Form 3 filing identifies Shane J. Hochradel, Chief Operations Officer of Alignment Healthcare, Inc., as a reporting person. It is an initial ownership report required when someone becomes an officer, director, or large shareholder, even if no specific transactions are reported.

Did Shane J. Hochradel report any trades in ALHC stock on this Form 3?

No trades are reported for Shane J. Hochradel on this Form 3. The transaction summary shows zero buys, zero sells, and no derivative exercises, indicating the filing only establishes reporting status without disclosing recent insider trading activity.

What role does Shane J. Hochradel hold at Alignment Healthcare (ALHC)?

Shane J. Hochradel is identified as the Chief Operations Officer of Alignment Healthcare, Inc. This officer status triggers ongoing reporting obligations for his equity interests in the company under insider ownership and transaction disclosure rules.

Does the ALHC Form 3 for Shane J. Hochradel include derivative securities?

The disclosed Form 3 data shows no derivative positions for Shane J. Hochradel. The derivative summary is empty and derivativeTransactionCount is zero, indicating no options, warrants, or similar instruments are listed in this initial ownership report.

What does the transaction summary on Shane J. Hochradel’s ALHC Form 3 indicate?

The transaction summary indicates zero buys, zero sells, zero gifts, and no tax withholding events. NetBuySellDirection is marked neutral, confirming that this Form 3 contains no insider trades and only sets up future reporting for the officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hochradel Shane J.

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY ROAD

SUITE 1600

(Street)

ORANGE CALIFORNIA 92868

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2026

3. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operations Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Power of Attorney Exh. 24.1

No securities are beneficially owned.

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Shane J. Hochradel	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)